The value of SCORAD and beyond. Towards a standardized evaluation of severity?
- PMID: 15245360
- DOI: 10.1111/j.1398-9995.2004.00651.x
The value of SCORAD and beyond. Towards a standardized evaluation of severity?
Abstract
The clinical scoring systems of atopic dermatitis were analysed and compared. Some biological parameters that can correlate with the clinical score were also reviewed. After the definition of the disease based on validated clinical criteria, the second necessity was the availability of reliable severity scores to allow clinicians to verify the course of the disease and the efficacy of treatments. After many proposals, the SCORAD (SCORing Atopic Dermatitis), that required more than three years of work, was the first one that was validated. SCORAD is freely available from an internet site and can be easily calculated using dedicated software. EASI (Eczema Area and Severity Index) score has also been validated but it has been modified twice. Simpler systems include SASSAD (Six Area, Six Sign Atopic Dermatitis) and TIS score (Three-Item Severity score). In parallel, biological parameters were investigated. Eosinophil cationic protein, circulating basophils, major basic protein, soluble E-selectin, antistaphylococcal enterotoxin B, immunoglobulin E titres and macrophage-derived chemokine, can correlate significantly with the clinical score. The clinicians will not benefit directly from laboratory techniques and will employ clinical scores.
Copyright 2004 Blackwell Munksgaard
Similar articles
-
Significance of interleukin-16, macrophage-derived chemokine, eosinophil cationic protein and soluble E-selectin in reflecting disease activity of atopic dermatitis--from laboratory parameters to clinical scores.Br J Dermatol. 2006 Jun;154(6):1112-7. doi: 10.1111/j.1365-2133.2006.07201.x. Br J Dermatol. 2006. PMID: 16704642
-
The new scoring system for evaluation of skin inflammation extent and severity in patients with atopic dermatitis.Acta Dermatovenerol Croat. 2005;13(4):219-24. Acta Dermatovenerol Croat. 2005. PMID: 16356394
-
Practical issues on interpretation of scoring atopic dermatitis: the SCORAD index, objective SCORAD and the three-item severity score.Br J Dermatol. 2007 Oct;157(4):645-8. doi: 10.1111/j.1365-2133.2007.08112.x. Epub 2007 Aug 21. Br J Dermatol. 2007. PMID: 17714568 Review.
-
The objective severity assessment of atopic dermatitis (OSAAD) score: validity, reliability and sensitivity in adult patients with atopic dermatitis.Br J Dermatol. 2005 Oct;153(4):767-73. doi: 10.1111/j.1365-2133.2005.06697.x. Br J Dermatol. 2005. PMID: 16181458
-
Assessment of clinical signs of atopic dermatitis: a systematic review and recommendation.J Allergy Clin Immunol. 2013 Dec;132(6):1337-47. doi: 10.1016/j.jaci.2013.07.008. Epub 2013 Sep 12. J Allergy Clin Immunol. 2013. PMID: 24035157 Review.
Cited by
-
SCORAD reflects the duration of atopic dermatitis lesions.Indian J Dermatol. 2013 May;58(3):247. doi: 10.4103/0019-5154.110893. Indian J Dermatol. 2013. PMID: 23723523 Free PMC article. No abstract available.
-
Treatment of eczema.Clin Rev Allergy Immunol. 2007 Dec;33(3):204-25. doi: 10.1007/s12016-007-0033-8. Clin Rev Allergy Immunol. 2007. PMID: 18163227 Review.
-
Local rhamnosoft, ceramides and L-isoleucine in atopic eczema: a randomized, placebo controlled trial.Pediatr Allergy Immunol. 2014 May;25(3):271-5. doi: 10.1111/pai.12227. Pediatr Allergy Immunol. 2014. PMID: 24750568 Free PMC article. Clinical Trial.
-
Atopic Dermatitis as a Multifactorial Skin Disorder. Can the Analysis of Pathophysiological Targets Represent the Winning Therapeutic Strategy?Pharmaceuticals (Basel). 2020 Nov 22;13(11):411. doi: 10.3390/ph13110411. Pharmaceuticals (Basel). 2020. PMID: 33266440 Free PMC article. Review.
-
Contribution of Antigen-Processing Machinery Genetic Polymorphisms to Atopic Dermatitis.Life (Basel). 2021 Apr 10;11(4):333. doi: 10.3390/life11040333. Life (Basel). 2021. PMID: 33920176 Free PMC article.
MeSH terms
LinkOut - more resources
Other Literature Sources